Exact Sciences
EXAS
$68.22
Share price
-1.36%
Change (1 day)
43.35%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Exact Sciences (EXAS) - Cash on Hand
Cash on Hand as of June 2023 : $0.77 B
According to Exact Sciences's latest financial reports the company has $0.77 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Exact Sciences - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.63 B | -38.66% |
| 2021-12-31 | $1.03 B | -44% |
| 2020-12-31 | $1.83 B | 468.5% |
| 2019-12-31 | $0.32 B | -71.21% |
| 2018-12-31 | $1.12 B | 164.69% |
| 2017-12-31 | $0.42 B | 36.52% |
| 2016-12-31 | $0.31 B | 1.38% |
| 2015-12-31 | $0.30 B | 8.53% |
| 2014-12-31 | $0.28 B | 112.19% |
| 2013-12-31 | $0.13 B | 23.25% |
| 2012-12-31 | $0.10 B | 15.81% |
| 2011-12-31 | $93.36 M | -2.15% |
| 2010-12-31 | $95.41 M | 292.2% |
| 2009-12-31 | $24.32 M | 392.77% |
| 2008-12-31 | $4.93 M | -60.78% |
| 2007-12-31 | $12.58 M | -40.28% |
| 2006-12-31 | $21.07 M | -38.23% |
| 2005-12-31 | $34.11 M | -32.14% |
| 2004-12-31 | $50.28 M | 80.82% |
| 2003-12-31 | $27.8 M | -36.58% |
| 2002-12-31 | $43.84 M | -22.86% |
| 2001-12-31 | $56.84 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $8.68 B | 1,019.85% | 🇫🇷 France |
 Veracyte VCYT | $0.19 B | -75.36% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.12 B | -84.32% | 🇺🇸 USA |
 Biocept
BIOC | $6.63 M | -99.14% | 🇺🇸 USA |